Where cartilage production is deficient, fibroblasts replace the region with generalized fibrous tissue.
The authors did not state whether their patients had TAMOF; however, one would not expect a benefit if TTP-like pathophysiology was the target (this needs up to 18 days of treatment), nor if DIC pathophysiology was the target (this needs full plasma replacement to replace deficient anti-coagulant proteins).
In the case of industrial, solvent-producing Clostridium species, the source of nitrogen affects solvent yield and when nitrogen deficient molasses replaced historical corn mash as a feed stock, nitrogenous compounds had to be added to the fermentation [ 51].
Anaplerotic metabolites of triheptanoin have the potential to replace deficient tricarboxylic acid (TCA) cycle intermediates, resulting in net glucose production as a novel energy source for the treatment of LC-FAOD.
Thus, development of new therapies to replace deficient IFN responses in these conditions is also likely to be of clinical benefit.
Although we have no evidence that these complexes are functional in the LBP or TBP fractions, it is possible that other isozymes replace deficient ones, as shown in this study.
Probucol had no significant effect on OXPHOS pathway upregulation that occurs in these primary mitochondrial RC mutants, consistent with its apparent inability to serve as an electron acceptor to replace deficient CoQ in the RC.
During 1831 1832, a prescient W.B. O'Shaughnessy noted that the purpose of treatment should be "to restore specific gravity of blood and replace deficient saline matter" in the blood of cholera patients, prompting Thomas Latta in Scotland to use intravenous fluid replacement therapy with water and salt.
Mechanisms of successful aging are based on: 1) persistence of normal function and plasticity, 2) compensatory responses to restore normal function, 3) interventions to replace deficient functions, 4) changing of health outcome by modifying risk profiles, 5) prevention of disease, and 6) strengthening of social interactions and support (Rowe and Kahn 1998).
Cell therapy for haemophilia is based, mainly, in transplantation of healthy cells to replace the deficient function, for example, the transplantation of liver sinusoidal endothelial cells or endothelial progenitor cells derived from iPSCs.
